Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium

计划入组 70 人 · 首次发布于 2016 年 7 月 13 日

A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia

计划入组 171 人 · 首次发布于 2025 年 7 月 25 日

An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients

计划入组 172 人 · 首次发布于 2025 年 4 月 11 日

Trospium Chloride/Xanomeline

Xanomeline Tartrate and Trospium Chloride

Xanomeline

C₁₄H₂₃N₃OS

Xanomeline/Trospium Chloride (COBENFY™) Approved for Schizophrenia Treatment

Xanomeline Trospium Shows Promising Cognitive Benefits in Schizophrenia Patients with Baseline Impairment

Xanomeline-Trospium Shows Consistent Efficacy in Schizophrenia Across Pooled Phase 3 Trials